Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
1.
Int J Oral Maxillofac Surg ; 45(10): 1280-2, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27515851

RESUMO

The first case of an oral infection caused by Sphingomonas paucimobilis is reported. A 73-year-old man presented with a gingival ulcer with bone exposure affecting the attached gingiva in the anterior maxillary region. He reported pain during chewing and the presence of fever. Since the first case of S. paucimobilis infection was reported in 1977, involving a leg ulcer, the number of reports related to this organism has been increasing, indicating that the bacterium should be considered an emerging pathogen. It is possible that other non-classical pathogens of the oral cavity may be responsible for infectious lesions, which represents a diagnostic and therapeutic challenge.


Assuntos
Doenças da Gengiva/microbiologia , Infecções por Bactérias Gram-Negativas/complicações , Úlceras Orais/microbiologia , Sphingomonas , Idoso , Febre/microbiologia , Infecções por Bactérias Gram-Negativas/microbiologia , Humanos , Masculino
2.
Biogerontology ; 15(1): 65-79, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24243066

RESUMO

Proinflammatory cytokines and heat shock proteins play relevant roles in the pathogenesis of inflammatory diseases. We investigated whether Hsp70 1267 A/G and TNF-α -308 G/A polymorphisms are associated with proinflammatory mediators, zinc status and laboratory parameters in 1,078 healthy elderly from ZincAge study. Hsp70 1267 A/G genotype and allele distribution were similar among various European countries, while a TNF-α genetic heterogeneity was observed between the Northern and the Southern European populations, with a major frequency of the -308 A variant in France, Germany and Poland. We used linear regression models to test additive, dominant or recessive associations of each SNP with proinflammatory mediators, laboratory parameters, metallothioneins and zinc status. Hsp70 1267 A/G SNP, but not TNF-α -308 G/A SNP, influences TNF-α and IL-6 plasma levels under additive, dominant and recessive models (for TNF-α only). An association between Hsp70 1267 A/G SNP and zinc plasma levels was observed in the dominant model. In particular, G allele carriers showed increased circulating pro-inflammatory cytokines and zinc. Moreover, both these SNPs affect creatinine levels suggesting a possible influence on renal function. In conclusion, Hsp70 1267 A/G SNP is associated with pro-inflammatory cytokine production in healthy elderly and might represent a possible determinant of individual susceptibility to inflammatory diseases.


Assuntos
Envelhecimento/metabolismo , Citocinas/sangue , Proteínas de Choque Térmico HSP70/genética , Inflamação/sangue , Polimorfismo de Nucleotídeo Único/genética , Fator de Necrose Tumoral alfa/genética , Zinco/metabolismo , Idoso , Idoso de 80 Anos ou mais , Envelhecimento/genética , Proteína C-Reativa/metabolismo , Europa (Continente) , Feminino , Frequência do Gene/genética , Genótipo , Homeostase/fisiologia , Humanos , Inflamação/genética , Masculino , Metalotioneína/metabolismo , Pessoa de Meia-Idade
3.
Clin Biochem ; 38(12): 1112-9, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16183049

RESUMO

OBJECTIVES: The aim of this study was to investigate transthyretin (prealbumin) effects on Abeta25-35-induced cytotoxicity. DESIGN AND METHODS: In view of the well-recognized literature data demonstrating that Abeta25-35 fibrillar aggregates cause in vitro cytotoxicity to human red blood cells and apoptotic changes to SK-N-BE neuroblastoma cells in cultures (ultrastructural evidence), we tested transthyretin effects on these two experimental models. RESULTS: Incubation of Abeta25-35 with transthyretin (at transthyretin concentrations equal to CSF physiological levels) demonstrated both inhibition of red blood cells lysis and neutralization of SK-N-BE neuroblastoma cells ultrastructural apoptotic changes. Moreover, transthyretin was shown to be able to inhibit the formation of fibrillar macroaggregates of Abeta25-35. CONCLUSIONS: The findings imply that experimental systems investigating Abeta-induced cytotoxicity consider the protective interaction of transthyretin with Abeta; an interaction to be considered also in vivo in view of the fact that transthyretin immunoreactivity has been previously demonstrated in amyloid plaques of brains from Alzheimer's disease patients.


Assuntos
Peptídeos beta-Amiloides/antagonistas & inibidores , Eritrócitos/efeitos dos fármacos , Neuroblastoma/tratamento farmacológico , Fragmentos de Peptídeos/antagonistas & inibidores , Pré-Albumina/farmacologia , Sequência de Aminoácidos , Peptídeos beta-Amiloides/metabolismo , Peptídeos beta-Amiloides/toxicidade , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Vermelho Congo/química , Eletroforese em Gel de Poliacrilamida , Hemólise/efeitos dos fármacos , Humanos , Técnicas In Vitro , Dados de Sequência Molecular , Neuroblastoma/patologia , Fragmentos de Peptídeos/metabolismo , Fragmentos de Peptídeos/toxicidade , Pré-Albumina/análise , Sensibilidade e Especificidade , Espectrofotometria/métodos , Células Tumorais Cultivadas
4.
Dig Liver Dis ; 36(10): 671-6, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15506666

RESUMO

BACKGROUND: So far the reliability of the anti-guinea pig and anti-human tissue transglutaminase antibodies for the coeliac disease diagnosis has been evaluated in selected groups of patients. AIM: To compare the diagnostic accuracy of anti-human versus anti-guinea pig tissue transglutaminase in the coeliac disease screening of the general population. SUBJECTS: Two healthy Italian populations living in Marche region and in Western Sardinia. METHODS: Both anti-guinea pig and anti-human tissue transglutaminase were determined using an enzyme-linked immunosorbent assay-based commercially available kit (Eu-tTG, Eurospital, Trieste, Italy). RESULTS: During the period 1999-2001, 3541 subjects (1500 from "continental" Italy and 2041 from Sardinia) were screened for coeliac disease using both anti-guinea pig and anti-human tissue transglutaminase as first-level tests. Both these tests were negative in 3439/3541 sera, while 29 resulted positive for both of them and 73 showed discordant results. Overall, 50 intestinal biopsies were performed in 22, 21 and 7 subjects with positivity to both screening tests, to anti-guinea pig and to anti-human tissue transglutaminase alone, respectively. A coeliac disease diagnosis was made in 25 subjects giving an overall prevalence of 1:126 individuals. The anti-tissue transglutaminase specificity and sensitivity were 98 and 92% for guinea pig and 99.6 and 96% for human tissue transglutaminase, respectively. CONCLUSIONS: The anti-human tissue transglutaminase test should definitely replace the anti-guinea pig-derived one as first-level screening tool for identifying all subjects who need the second-level investigations (small intestinal biopsy).


Assuntos
Anticorpos/sangue , Doença Celíaca/diagnóstico , Transglutaminases/imunologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Doença Celíaca/sangue , Ensaio de Imunoadsorção Enzimática , Cobaias , Humanos , Itália , Programas de Rastreamento/métodos , Pessoa de Meia-Idade , Sensibilidade e Especificidade
5.
J Pept Sci ; 7(12): 626-40, 2001 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11798019

RESUMO

Three linear Thr6-bradykinin analogues in which either one or both the two phenylalanine residues in the peptide sequence have been substituted by N-benzylglycine (BzlGly) and their head-to-tail cyclic analogues were synthesized and tested on an isolated rat duodenum preparation. The linear (BzlGly5,Thr6-BK, BzlGly8,Thr6-BK and BzlGly(5,8),Thr6-BK) and the cyclic (cyclo BzlGly5,Thr6-BK, cyclo BzlGly8,Thr6-BK and cyclo BzlGly(5,8),Thr6-BK) peptoid-like analogues were characterized by amino acid analysis, optical rotation, analytical HPLC and MALDI-TOF mass spectroscopy. The conformational features of both the linear and cyclic derivatives were investigated by FT-IR and CD measurements. Preliminary molecular mechanics calculations were also performed on some synthetic peptides. Pharmacological screening using the relaxation of the isolated rat duodenum preparation showed that incorporation of N-benzylglycine at positions 5 and/or 8 in the linear Thr6-BK causes a substantial decrease in potency. Comparable incorporation in cyclo Thr6-BK, at position 8, or 5 and 8, resulted in nearly inactive analogues. However, cyclo BzlGly5,Thr6-BK showed a potency which is of the same order of magnitude as for cyclo-BK and cyclo Thr6-BK.


Assuntos
Bradicinina/química , Bradicinina/síntese química , Glicina/análogos & derivados , Glicina/química , Fenilalanina/química , Treonina/química , Cromatografia Líquida de Alta Pressão , Dicroísmo Circular , Biossíntese Peptídica , Peptídeos/química , Peptoides , Conformação Proteica , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Espectrofotometria Infravermelho , Espectroscopia de Infravermelho com Transformada de Fourier
6.
Adv Ther ; 18(6): 261-71, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11841196

RESUMO

Systemic glucocorticosteroids have demonstrated efficacy in ulcerative colitis (UC) but cause undesired systemic side effects. Beclomethasone dipropionate (BDP) has potent topical activity and is extensively metabolized. This randomized double-blind study investigated an oral gastroresistant controlled-release preparation of BDP in 57 patients with mild to moderately severe extensive or left-sided UC. Patients were assigned to receive BDP 5 or 10 mg/d; a third group took a clinically inactive dose (1.6 g/d) of 5-aminosalicylic acid (5-ASA). Both BDP doses displayed excellent efficacy confirmed by results of endoscopy, biopsy, and clinical evaluation. Significant improvement from baseline occurred in most signs and symptoms of UC, particularly stool frequency, rectal bleeding, and mucus in the stool (P<.01). Tolerability was good in both BDP groups. Morning plasma cortisol levels decreased significantly from baseline with BDP 10 mg, but no significant changes in vital signs were observed at the end of treatment. Despite a small sample size and the open comparison with 5-ASA, this multicenter study showed the therapeutic equivalence of BDP 5 and 10 mg/d in alleviating clinical symptoms and improving endoscopic and biopsy scores in patients with mild to moderate UC. BDP 5 mg/d displayed better general tolerability and less reduction of plasma cortisol levels, however, and may be preferable to the higher dose in this indication.


Assuntos
Beclometasona/administração & dosagem , Colite Ulcerativa/tratamento farmacológico , Glucocorticoides/administração & dosagem , Administração Oral , Adolescente , Adulto , Idoso , Análise de Variância , Beclometasona/farmacologia , Colite Ulcerativa/patologia , Preparações de Ação Retardada , Relação Dose-Resposta a Droga , Método Duplo-Cego , Feminino , Glucocorticoides/farmacologia , Humanos , Masculino , Pessoa de Meia-Idade , Estatísticas não Paramétricas
7.
Br J Clin Pharmacol ; 49(2): 158-67, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10671911

RESUMO

AIMS: To explore drug exposure, frequency of adverse drug reactions (ADRs), types of ADRs, predisposing risk factors and ADR-related excess hospital stay in medical inpatients. METHODS: Structured data regarding patient characteristics, 'events' (symptoms, laboratory results), diagnoses (ICD10) and drug therapy were collected using a computer-supported data entry system and an interface for data retrieval from electronic patient records. ADR data were collected by 'event monitoring' to minimize possible bias by the drug monitor. The causality of each event was assessed in relation to disease(s) and drug therapy. RESULTS: The analysis included 4331 (100%) hospitalizations. The median observation period was 8 days. The median number of different drugs administered per patient and day was 6 and varied between 4 (Q1 ) and 9 (Q3 ) different drugs in 50% of all hospital days. In 41% of all hospitalizations at least one disease-unrelated event could be possibly attributed to drug therapy. Clinically relevant ADRs occurred in 11% of all hospitalizations. In 3.3% of all hospitalizations ADRs were the cause of hospital admission. The incidence of possibly ADR-related deaths was 1.4. Factors predisposing for clinically relevant ADRs were female gender and polypharmacy. ADR-related excess hospital stay accounted for 8. 6% of hospital days. CONCLUSIONS: These data demonstrate the feasibility of the developed 'event monitoring' system for quantitative analysis of ADRs in medical inpatients. With increasing numbers of recorded patients the pharmacoepidemiological database provides a valuable tool to study specific questions regarding drug efficacy and safety in hospitalized patients.


Assuntos
Sistemas de Notificação de Reações Adversas a Medicamentos/estatística & dados numéricos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Hospitais de Ensino/estatística & dados numéricos , Fatores Etários , Agranulocitose/induzido quimicamente , Agranulocitose/mortalidade , Angioedema/induzido quimicamente , Angioedema/mortalidade , Estudos de Coortes , Doença/etiologia , Tratamento Farmacológico/estatística & dados numéricos , Feminino , Gastroenteropatias/induzido quimicamente , Gastroenteropatias/epidemiologia , Doenças Hematológicas/induzido quimicamente , Doenças Hematológicas/epidemiologia , Hospitalização , Humanos , Medicina Interna , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Polimedicação , Fatores de Risco , Fatores Sexuais , Suíça/epidemiologia
8.
Praxis (Bern 1994) ; 88(39): 1581-5, 1999 Sep 23.
Artigo em Alemão | MEDLINE | ID: mdl-10540570

RESUMO

The 57 year old woman presented with diffuse muscle spasms and delirium. Prior to presentation, she complained of progressive muscle pain, weakness and a weight loss of 10 kg over several months. Laboratory investigation showed hypopituitarism and a syndrome of inappropriate antidiuretic hormone secretion. Magnetic resonance imaging revealed an empty sella. The primary and secondary syndromes of empty sella are discussed.


Assuntos
Doenças Reumáticas/diagnóstico , Doenças Reumáticas/etiologia , Síndrome da Sela Vazia/complicações , Síndrome da Sela Vazia/diagnóstico , Feminino , Humanos , Hipopituitarismo/diagnóstico , Hipopituitarismo/etiologia , Síndrome de Secreção Inadequada de HAD/diagnóstico , Síndrome de Secreção Inadequada de HAD/etiologia , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade
10.
Clin Endocrinol (Oxf) ; 50(3): 399-403, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10435068

RESUMO

A 44-year-old man with a history of Whipple's disease 8 years ago presented with recurrent grand mal seizures and signs of hypopituitarism on physical examination. Magnetic resonance imaging of the brain revealed a hypothalamic lesion of 1 cm diameter in the region of the rostral infundibulum. Hypopituitarism was confirmed by low levels of serum cortisol, free testosterone and free thyroxine without an elevated TSH. Whipple encephalitis with hypothalamic involvement was suggested and verified by positive polymerase chain reaction (PCR) for Tropheryma whippelii in the cerebrospinal fluid. PCR for T. whippelii has become an important diagnostic tool for establishing the diagnosis of Whipple's disease especially in patients with unusual presentations and if the diagnosis cannot be confirmed histologically. Whipple's disease should be included in the differential diagnosis in hypopituitarism caused by infectious disease.


Assuntos
Actinobacteria/genética , DNA Bacteriano/líquido cefalorraquidiano , Hipopituitarismo/microbiologia , Doença de Whipple/complicações , Infecções por Actinomycetales/líquido cefalorraquidiano , Infecções por Actinomycetales/microbiologia , Adulto , Humanos , Hipopituitarismo/líquido cefalorraquidiano , Hipopituitarismo/diagnóstico , Imageamento por Ressonância Magnética , Masculino , Reação em Cadeia da Polimerase , Doença de Whipple/líquido cefalorraquidiano , Doença de Whipple/diagnóstico
11.
Praxis (Bern 1994) ; 88(19): 871-5, 1999 May 06.
Artigo em Alemão | MEDLINE | ID: mdl-10409886

RESUMO

We report a 29 year old female drug addict seen in the emergency room with neck abscesses, dysphagia and a symmetric ptosis. Initially misinterpreted as adverse effect of illegal drug intake these symptoms were due to myasthenia gravis. This case shows an important differential diagnosis of ptosis common in drug addicts.


Assuntos
Blefaroptose/etiologia , Transtornos Relacionados ao Uso de Cocaína/complicações , Dependência de Heroína/complicações , Miastenia Gravis/diagnóstico , Abuso de Substâncias por Via Intravenosa/complicações , Adulto , Blefaroptose/induzido quimicamente , Transtornos Relacionados ao Uso de Cocaína/diagnóstico , Diagnóstico Diferencial , Feminino , Dependência de Heroína/diagnóstico , Humanos
12.
Schweiz Med Wochenschr ; 129(23): 890-5, 1999 Jun 12.
Artigo em Alemão | MEDLINE | ID: mdl-10420445

RESUMO

Ectopic ACTH secretion due to malignant tumours is the most frequently underdiagnosed form of Cushing's syndrome. The majority of neoplasms causing ectopic ACTH syndrome are small-cell cancers of the lung or carcinoids. Other well-documented cases include adenocarcinoma of the lung, medullary thyroid carcinoma, pancreatic islet tumours and malignant thymoma. We report a rare case of metastatic colonic adenocarcinoma with ectopic ACTH syndrome. Clinical features such as proximal muscle weakness, peripheral oedema, hypertension or hirsutism in women, or the presence of unexplained hyperglycaemia, hypokalaemia or metabolic alkalosis in patients with known malignancy strongly suggest ectopic ACTH syndrome. Removal of the source of ACTH is the treatment of first choice, but often not feasible. Most often, treatment modalities are only palliative, with drugs directed against hypercortisolism such as aminoglutethimide, metyrapone, ketoconazole or mifepristone.


Assuntos
Síndrome de ACTH Ectópico/etiologia , Adenocarcinoma/complicações , Adenocarcinoma/diagnóstico , Erros de Diagnóstico , Neoplasias do Colo Sigmoide/complicações , Neoplasias do Colo Sigmoide/diagnóstico , Síndrome de ACTH Ectópico/diagnóstico , Síndrome de ACTH Ectópico/terapia , Adenocarcinoma/metabolismo , Adenocarcinoma/terapia , Aminoglutetimida/uso terapêutico , Antineoplásicos Hormonais/uso terapêutico , Evolução Fatal , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias Ovarianas/diagnóstico , Neoplasias Ovarianas/cirurgia , Cuidados Paliativos , Neoplasias do Colo Sigmoide/metabolismo , Neoplasias do Colo Sigmoide/terapia
13.
Aliment Pharmacol Ther ; 12(4): 361-6, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9690726

RESUMO

AIM: To compare beclomethasone dipropionate 3 mg/60 mL enema (BDP) and prednisolone sodium phosphate 30 mg/60 mL enema (PP) once daily in patients with active distal ulcerative colitis. METHODS: One hundred and fifty-seven patients were enrolled in a multicentre, 4-week, randomized, double-blind trial. Patients were assessed at baseline, 2 and 4 weeks. RESULTS: Both treatment groups showed statistically significant improvement of clinical activity after 2 and 4 weeks. Endoscopy and biopsy showed a reduction in the activity score at the end of the treatment period in both groups. No statistically significant difference was observed between the two treatment groups. After 4 weeks, 29% of patients in the BDP group and 25% in the PP group were considered to be in clinical remission; an improvement was observed in 40% of patients on BDP and in 47% on PP. Mean morning plasma cortisol levels showed a slight but significant reduction in the PP group, while the ACTH test showed that neither drug interfered with the hypothalamic-pituitary-adrenal (HPA) axis function. No significant changes were observed in the laboratory tests. Finally, there was a low incidence of adverse events in both groups. CONCLUSIONS: It is concluded that, in the topical treatment of active distal ulcerative colitis, BDP 3 mg enemas are as efficacious as PP 30 mg enemas, without interference with the HPA axis.


Assuntos
Anti-Inflamatórios/uso terapêutico , Beclometasona/uso terapêutico , Colite Ulcerativa/tratamento farmacológico , Glucocorticoides/uso terapêutico , Prednisolona/análogos & derivados , Administração Tópica , Adulto , Anti-Inflamatórios/administração & dosagem , Beclometasona/administração & dosagem , Colite Ulcerativa/patologia , Método Duplo-Cego , Enema , Feminino , Glucocorticoides/administração & dosagem , Humanos , Masculino , Prednisolona/administração & dosagem , Prednisolona/uso terapêutico , Resultado do Tratamento
14.
Praxis (Bern 1994) ; 84(25-26): 778-83, 1995 Jun 20.
Artigo em Francês | MEDLINE | ID: mdl-7597365

RESUMO

In clinical endocrinology an elevated prolactin concentration in serum is often encountered. This may be either physiological during pregnancy and lactation or pathological in all other cases. The most frequent causes are drugs (dopamine antagonists, estrogens) and primary hypothyroidism. These hyperprolactinemic states have to be distinguished from prolactinomas and other tumors of the pituitary gland, which can increase the level of prolactin in the serum through different mechanisms. Drug therapy with dopamine agonists will almost always decrease prolactin levels, but will rarely cure the disease. Long-term success rates after surgery are 50% for microadenomas and 10 to 15% for macroadenomas. Therefore, the decision to operate should be made after careful discussion between the surgeon and the endocrinologist. Pregnancy will rarely cause expansion of the tumors, more often with macro- than with microadenomas. Pregnant women with prolactinomas have to be followed clinically, and drug therapy has to be instituted immediately when clinical signs of tumor progression exist.


Assuntos
Hiperprolactinemia/fisiopatologia , Adenoma/fisiopatologia , Adenoma/cirurgia , Agonistas de Dopamina/uso terapêutico , Feminino , Humanos , Hiperprolactinemia/etiologia , Hiperprolactinemia/terapia , Hipofisectomia/métodos , Neoplasias Hipofisárias/fisiopatologia , Neoplasias Hipofisárias/cirurgia , Gravidez , Complicações na Gravidez/fisiopatologia , Complicações Neoplásicas na Gravidez/fisiopatologia , Prolactinoma/fisiopatologia , Prolactinoma/cirurgia
15.
Schweiz Med Wochenschr ; 125(14): 684-7, 1995 Apr 08.
Artigo em Alemão | MEDLINE | ID: mdl-7732347

RESUMO

Endocrine disorders in the course of HIV infection are often a result of opportunistic infections of endocrine organs. We describe the case of a 30-year-old HIV positive man in whom diabetes insipidus developed initially with no abnormal findings in cranial magnetic resonance imaging. 2 months later the patient presented with symptoms of panhypopituitarism. At this time, neuroradiologic examination was consistent with cerebral toxoplasmosis. Symptoms and neuroradiologic findings improved after treatment for cerebral toxoplasmosis. Toxoplasmosis is the most frequent opportunistic infection of the brain in patients with AIDS. In HIV positive patients with malfunction of the hypothalamic-hypophyseal system cerebral toxoplasmosis must be considered in differential diagnosis. Treatment of this disorder may alleviate symptoms and signs of endocrine malfunction.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/diagnóstico , Síndrome da Imunodeficiência Adquirida/complicações , Diabetes Insípido/complicações , Hipopituitarismo/complicações , Toxoplasmose Cerebral/diagnóstico , Adulto , Encéfalo/patologia , Humanos , Hipopituitarismo/diagnóstico , Imageamento por Ressonância Magnética , Masculino , Toxoplasmose Cerebral/complicações
16.
Ther Umsch ; 49(2): 86-92, 1992 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-1553629

RESUMO

There are only a few systematic epidemiological studies concerning the frequency of adverse reactions (AR) to natural remedies. However, there are numerous case reports which sometimes also include some detailed pathophysiological investigations. In general, four different categories of side effects to natural remedies can be distinguished: 1--at normal use; 2--at excessive use; in this regard many publications exist, since natural products are generally assumed to be safe and, therefore, are frequently taken in overdose; 3--induced by falsified products, e.g. through addition of steroids to for example "natural" antiasthmatics; 4--induced through omission of an efficient and proven therapy because of unshakable believe in "nature". Since conclusive studies in this matter are methodologically cumbersome and very difficult to perform, two newer studies that address these problems in special situations (oncologic patients) are the more interesting.


Assuntos
Naturologia/efeitos adversos , Intoxicação/etiologia , Contaminação de Medicamentos , Humanos
17.
Schweiz Med Wochenschr ; 121(30): 1095-8, 1991 Jul 27.
Artigo em Alemão | MEDLINE | ID: mdl-1866607

RESUMO

We report the first case in the literature of human infection with Rhodococcus erythropolis in an HIV-positive patient. A 24-year-old bisexual flight attendant had severe HIV-associated immunodeficiency with a CD4 cell count of 0.02 G/l. He complained of multiple subcutaneous nodules at different sites on the extremities. Biopsy of one node at his left knee revealed granulomatous inflammation filled with acid-fast rods. These bacteria were identified as Rhodococcus erythropolis. The disseminated infection was restricted to the skin and showed a slow response to long-term therapy with amoxicillin/clavulanic acid. No relapse has been observed more than 6 months after discontinuation of antibiotic therapy. The etiology of a concomitant polyarthritis remains unknown; a relationship with the rhodococcus infection is possible as the arthritis responded well to the antibiotic therapy and did not reactivate after discontinuation of antibiotics. Due to the difficult isolation technic, this pathogen may be overlooked in routine diagnostic procedures. The implications in clinical practice are discussed.


Assuntos
Infecções por Actinomycetales/microbiologia , Infecções por HIV/complicações , Rhodococcus , Infecções por Actinomycetales/complicações , Infecções por Actinomycetales/tratamento farmacológico , Adulto , Amoxicilina/administração & dosagem , Artrite Infecciosa/complicações , Ácido Clavulânico , Ácidos Clavulânicos/administração & dosagem , Quimioterapia Combinada/uso terapêutico , Inibidores Enzimáticos/administração & dosagem , Humanos , Masculino , Inibidores de beta-Lactamases
18.
Boll Ist Sieroter Milan ; 66(5): 384-8, 1987.
Artigo em Italiano | MEDLINE | ID: mdl-3449100

RESUMO

Biopsy specimens from antral mucosa in 65 consecutive patients presenting for gastroscopy were assessed histologically and microbiologically for the presence of C. pyloridis. Spiral bacteria were found in 63% of cases by Warthin-Starry silver stain and in 72% by culture on blood agar plates with Skirrow's antibiotic supplement. A significant association between the occurrence of C. pyloridis and chronic gastritis was noted; the association is not influenced by the type of gastritis, superficial or atrophic, or the degree of activity of gastritis.


Assuntos
Infecções por Campylobacter/microbiologia , Gastrite/microbiologia , Adolescente , Adulto , Idoso , Biópsia , Infecções por Campylobacter/patologia , Feminino , Mucosa Gástrica/patologia , Gastrite/patologia , Humanos , Masculino
19.
Schweiz Med Wochenschr ; 116(39): 1326-31, 1986 Sep 27.
Artigo em Alemão | MEDLINE | ID: mdl-3095918

RESUMO

The case is reported of a 32-year-old woman with polyneuropathy, organomegaly, edema, endocrinopathy, dark skin and solitary myeloma with monoclonal gammopathy of IgG/lambda type. More than 100 cases of this rare disorder have been observed up to now, mainly in Japan. In recent reviews the terms POEMS-syndrome or Crow-Fukase-syndrome have been used. Local radiotherapy of the myeloma led to lasting regression of symptoms. Studies with immunocytochemistry and immunoelectroblotting revealed specific antibody activity against hypophysis, suggesting that the pathologic monoclonal myeloma antibodies may damage the neuroendocrinic centers in hypothalamus and hypophysis as the primary target. Most of the multisystemic symptoms would thus be explained as secondary alterations.


Assuntos
Doenças do Sistema Endócrino/etiologia , Hepatomegalia/etiologia , Doenças do Sistema Nervoso/etiologia , Transtornos da Pigmentação/etiologia , Plasmocitoma/complicações , Esplenomegalia/etiologia , Adulto , Doenças do Sistema Endócrino/diagnóstico , Doenças do Sistema Endócrino/patologia , Feminino , Hepatomegalia/diagnóstico , Hepatomegalia/patologia , Humanos , Cadeias lambda de Imunoglobulina , Gamopatia Monoclonal de Significância Indeterminada/diagnóstico , Gamopatia Monoclonal de Significância Indeterminada/patologia , Doenças do Sistema Nervoso/diagnóstico , Doenças do Sistema Nervoso/patologia , Transtornos da Pigmentação/diagnóstico , Transtornos da Pigmentação/patologia , Plasmocitoma/diagnóstico , Plasmocitoma/patologia , Esplenomegalia/diagnóstico , Esplenomegalia/patologia
20.
Clin Pharmacol Ther ; 39(6): 619-24, 1986 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-3519041

RESUMO

Alizapride is a new substituted benzamide with suggested superior antiemetic efficacy to and fewer side effects than metoclopramide. High-dose alizapride (4 mg/kg X five doses) was compared with high-dose metoclopramide (2 mg/kg X five doses) in a prospective, randomized, double-blind trial in 62 evaluable patients undergoing strongly emetic cancer chemotherapy. Patients receiving metoclopramide experienced significantly fewer vomiting episodes than patients receiving alizapride (median of three episodes vs. eight episodes; P less than 0.001). Metoclopramide was more effective in decreasing the volume of emesis than was alizapride (median of 100 ml vs. 360 ml; P less than 0.02). Seventy-two percent of the patients receiving alizapride and 57% of those receiving metoclopramide experienced side effects. High-dose metoclopramide is an effective antiemetic in patients receiving cancer chemotherapy. Alizapride is less effective and has more side effects than metoclopramide. We do not recommend the further use of alizapride.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Metoclopramida/uso terapêutico , Náusea/prevenção & controle , Neoplasias/tratamento farmacológico , Pirrolidinas/uso terapêutico , Vômito/prevenção & controle , Adulto , Idoso , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Cisplatino/efeitos adversos , Cisplatino/uso terapêutico , Ensaios Clínicos como Assunto , Método Duplo-Cego , Avaliação de Medicamentos , Feminino , Humanos , Infusões Parenterais , Masculino , Metoclopramida/efeitos adversos , Pessoa de Meia-Idade , Náusea/induzido quimicamente , Estudos Prospectivos , Pirrolidinas/efeitos adversos , Distribuição Aleatória , Vômito/induzido quimicamente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA